ARK Investment Management’s Pfizer PFE Stock Holding History

ARK Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-499,757	Closed	-$14.4M	–	230
2023 Q4	$14.4M	Buy	499,757 +35,677	+8%	+$1.08M	0.09%	96
2023 Q3	$15.4M	Sell	464,080 -1,521	-0.3%	-$53.8K	0.12%	91
2023 Q2	$17.1M	Sell	465,601 -19,189	-4%	-$747K	0.11%	92
2023 Q1	$19.8M	Sell	484,790 -6,765	-1%	-$292K	0.14%	74
2022 Q4	$25.2M	Sell	491,555 -41,257	-8%	-$1.98M	0.22%	58
2022 Q3	$23.3M	Sell	532,812 -201,353	-27%	-$9.78M	0.16%	76
2022 Q2	$38.9M	Sell	734,165 -25,766	-3%	-$1.31M	0.23%	66
2022 Q1	$39.3M	Sell	759,931 -183,918	-19%	-$9.54M	0.16%	78
2021 Q4	$55.7M	Sell	943,849 -1,273,820	-57%	-$63.1M	0.17%	80
2021 Q3	$95.4M	Buy	+2,217,669	New	+$98.2M	0.23%	72

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

ARK Investment Management's PFE Position: Q1 2024 in Review

ARK Investment Management sold out of Pfizer (PFE) in Q1 2024, closing a stake of 499,757 shares — an estimated $14.4M sold.

ARK Investment Management first reported a position in PFE in Q3 2021 and held it in 10 quarters. The position peaked at $95.4M in Q3 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

ARK Investment Management reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
ARK Investment Management sold 499,757 Pfizer shares in Q1 2024, an estimated $14.4M.
ARK Investment Management first reported a position in Pfizer in Q3 2021 and held it in 10 quarters.
ARK Investment Management's Pfizer position peaked at $95.4M in Q3 2021.
2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on ARK Investment Management's 13F filing for Q1 2024, filed 18 Apr 2024.